Send us Fan Mail

Ready for a deep dive into the intricate world of managing A-fibrillation? Here's your golden ticket! In our latest MedEvidence episode, Dr. Neil Sanghvi and Dr. Michael Koren peel back the layers to reveal the most effective therapies for this condition. We tackle the tough decisions, like choosing between anticoagulation and a left atrial closure device, and shed light on exciting research developments in the field. You'll get a swift education in the coagulation cascade, the Watchman device and the Champion trial, which compares the efficacy of anticoagulants and device implantation.

As we navigate further down the rabbit hole, we delve into the potential benefits of A-Fib ablation to manage symptoms, the indications for anticoagulants, and the impact of clinical research on therapy advancement. Prepare to be riveted as we discuss the transition off anticoagulants post-device placement and explore the role of genetics in A-fibrillation. We also touch upon the incorporation of artificial intelligence and other game-changing technologies to identify A-fibrillation and predict complications. We wrap up the episode with a candid discussion about the potential risks of ablation, mitigation strategies, and the irreplaceable value of follow-up care after A-Fib ablation. If you're looking for powerful insights and wisdom from the field of medicine, this episode of MedEvidence is a must-listen.

Recording Date April 20, 2023

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!